CHINA PHARMA HOLDINGS, INC. Accounts Payable, Trade, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accounts Payable, Trade, Current of $734.04 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current › Accounts Payable, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Trade, Current $734.04K.
- 2026-03-31: Accounts Payable, Trade, Current $837.11K.
- 2025-12-31: Accounts Payable, Trade, Current $891.08K.
- 2025-09-30: Accounts Payable, Trade, Current $588.74K.
| Period end | Accounts Payable, Trade, Current | Accounts Payable, Trade, Current as first filed |
|---|---|---|
| 2026-06-30 | $734.04K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $837.11K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $891.08K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $588.74K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $530.73K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $548.26K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $225.11K 10-K · filed 2026-04-01 | |
| 2024-09-30 | $390.24K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $141.04K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $966.42K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $831.30K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $414.08K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $848.91K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $667.08K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $435.61K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $397.54K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $927.35K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $926.75K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $599.70K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $687.05K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.11M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.23M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $989.64K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.03M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $847.76K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.37M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $1.16M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.28M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.09M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.06M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $588.72K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.15M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.38M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.14M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $1.89M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $2.15M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $2.88M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $3.06M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $3.48M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.86M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $3.74M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $2.44M 10-K · filed 2017-03-31 | $2.82M 10-K · filed 2016-03-30 |
| 2015-09-30 | $4.33M 10-Q · filed 2015-12-28 | |
| 2015-06-30 | $3.70M 10-Q · filed 2015-12-28 | |
| 2015-03-31 | $3.23M 10-Q · filed 2015-12-28 | |
| 2014-12-31 | $2.55M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $3.13M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $2.54M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $2.18M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.88M 10-K · filed 2015-12-28 | |
| 2013-09-30 | $3.30M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $4.32M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.98M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $2.84M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $4.79M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.90M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $3.11M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |